Baloxavir marboxil (Xofluza) is an antiviral medication with a novel mechanism that inhibits an influenza virus–specific enzyme necessary for viral gene transcription and prevents influenza A and B virus replication. Baloxavir is labeled for the treatment of acute uncomplicated influenza in patients 12 years and older who have been symptomatic for no more than 48 hours.